FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2047183713> ?p ?o ?g. }

• W2047183713 endingPage "e73655" @default.
• W2047183713 startingPage "e73655" @default.
• W2047183713 abstract "To determine whether delayed administration of a single dose of suramin, a drug that has been used extensively in humans to treat trypanosomiasis, attenuates renal injury in a leptin receptor deficient C57BLKS/J db/db type 2 diabetic nephropathy (T2DN) mouse model.Groups of female non-diabetic (control) db/m and diabetic db/db mice of 8 and 16 weeks of age, respectively, were treated with suramin (10 mg/kg) or saline i.v. All animals were euthanized one week later. Measurements in mice 1 week following treatment included the following: body weight; blood glucose; urinary protein excretion; pathological lesions in glomeruli and proximal tubules; changes in protein expression of pro-inflammatory transcription factor nuclear factor κB (NF-κB) and intracellular adhesion molecule-1 (ICAM-1), profibrotic transforming growth factor-β1 (TGF-β1), phospho-SMAD-3 and alpha-smooth muscle actin (α-SMA); and immunohistochemical analysis of leukocyte infiltration and collagen 1A2 (COL1A2) deposition.Immunoblot analysis revealed increased NF-κB, ICAM-1, TGF-β1, phospho-SMAD-3, and α-SMA proteins in both 9 and 17 week db/db mice as compared to db/m control mice. Immunohistochemical analysis revealed moderate leukocyte infiltration and collagen 1A2 (COL1A2) deposition in 9 week db/db mice that was increased in the 17 week db/db mice. Importantly, suramin significantly decreased expression of all these markers in 9 week db/db mice and partially decreased in 17 week db/db mice without altering body weight, blood glucose or urinary protein excretion. There was no difference in creatinine clearance between 9 week db/m and db/db mice ± suramin. Importantly, in the 17 week db/db mice suramin intervention reversed the impaired creatinine clearance and overt histological damage.Delayed administration of a single dose of suramin in a model of T2DN attenuated inflammation and fibrosis as well as improved renal function, supporting the use of suramin in T2DN." @default.
• W2047183713 created "2016-06-24" @default.
• W2047183713 creator A5000985765 @default.
• W2047183713 creator A5004628839 @default.
• W2047183713 creator A5013354704 @default.
• W2047183713 creator A5025217015 @default.
• W2047183713 creator A5027692251 @default.
• W2047183713 creator A5083302689 @default.
• W2047183713 date "2013-09-09" @default.
• W2047183713 modified "2023-10-10" @default.
• W2047183713 title "Suramin: A Potential Therapy for Diabetic Nephropathy" @default.
• W2047183713 cites W1587918753 @default.
• W2047183713 cites W1590579277 @default.
• W2047183713 cites W1592519647 @default.
• W2047183713 cites W1595278394 @default.
• W2047183713 cites W1966215425 @default.
• W2047183713 cites W1968446955 @default.
• W2047183713 cites W1969759922 @default.
• W2047183713 cites W1972187255 @default.
• W2047183713 cites W1980325398 @default.
• W2047183713 cites W1982670131 @default.
• W2047183713 cites W1987106360 @default.
• W2047183713 cites W1997173726 @default.
• W2047183713 cites W2000751240 @default.
• W2047183713 cites W2004543572 @default.
• W2047183713 cites W2008531705 @default.
• W2047183713 cites W2009826896 @default.
• W2047183713 cites W2011444708 @default.
• W2047183713 cites W2021017423 @default.
• W2047183713 cites W2048107895 @default.
• W2047183713 cites W2063177214 @default.
• W2047183713 cites W2071298657 @default.
• W2047183713 cites W2079703996 @default.
• W2047183713 cites W2089825480 @default.
• W2047183713 cites W2108266187 @default.
• W2047183713 cites W2109164958 @default.
• W2047183713 cites W2112673248 @default.
• W2047183713 cites W2113664327 @default.
• W2047183713 cites W2116197163 @default.
• W2047183713 cites W2121355767 @default.
• W2047183713 cites W2124502714 @default.
• W2047183713 cites W2136487005 @default.
• W2047183713 cites W2139518267 @default.
• W2047183713 cites W2143001791 @default.
• W2047183713 cites W2153291563 @default.
• W2047183713 cites W2161654899 @default.
• W2047183713 cites W2164367548 @default.
• W2047183713 cites W2170609859 @default.
• W2047183713 cites W2180781245 @default.
• W2047183713 cites W2297568899 @default.
• W2047183713 cites W2317423776 @default.
• W2047183713 cites W2321096221 @default.
• W2047183713 cites W2416046640 @default.
• W2047183713 cites W4231406756 @default.
• W2047183713 cites W4244774747 @default.
• W2047183713 cites W4294183732 @default.
• W2047183713 doi "https://doi.org/10.1371/journal.pone.0073655" @default.
• W2047183713 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3767615" @default.
• W2047183713 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24040012" @default.
• W2047183713 hasPublicationYear "2013" @default.
• W2047183713 type Work @default.
• W2047183713 sameAs 2047183713 @default.
• W2047183713 citedByCount "18" @default.
• W2047183713 countsByYear W20471837132015 @default.
• W2047183713 countsByYear W20471837132016 @default.
• W2047183713 countsByYear W20471837132018 @default.
• W2047183713 countsByYear W20471837132019 @default.
• W2047183713 countsByYear W20471837132021 @default.
• W2047183713 countsByYear W20471837132022 @default.
• W2047183713 countsByYear W20471837132023 @default.
• W2047183713 crossrefType "journal-article" @default.
• W2047183713 hasAuthorship W2047183713A5000985765 @default.
• W2047183713 hasAuthorship W2047183713A5004628839 @default.
• W2047183713 hasAuthorship W2047183713A5013354704 @default.
• W2047183713 hasAuthorship W2047183713A5025217015 @default.
• W2047183713 hasAuthorship W2047183713A5027692251 @default.
• W2047183713 hasAuthorship W2047183713A5083302689 @default.
• W2047183713 hasBestOaLocation W20471837131 @default.
• W2047183713 hasConcept C118131993 @default.
• W2047183713 hasConcept C126322002 @default.
• W2047183713 hasConcept C134018914 @default.
• W2047183713 hasConcept C170493617 @default.
• W2047183713 hasConcept C2776182878 @default.
• W2047183713 hasConcept C2778176769 @default.
• W2047183713 hasConcept C2779922275 @default.
• W2047183713 hasConcept C2780306776 @default.
• W2047183713 hasConcept C2781080636 @default.
• W2047183713 hasConcept C2781184683 @default.
• W2047183713 hasConcept C555293320 @default.
• W2047183713 hasConcept C71924100 @default.
• W2047183713 hasConceptScore W2047183713C118131993 @default.
• W2047183713 hasConceptScore W2047183713C126322002 @default.
• W2047183713 hasConceptScore W2047183713C134018914 @default.
• W2047183713 hasConceptScore W2047183713C170493617 @default.
• W2047183713 hasConceptScore W2047183713C2776182878 @default.
• W2047183713 hasConceptScore W2047183713C2778176769 @default.
• W2047183713 hasConceptScore W2047183713C2779922275 @default.
• W2047183713 hasConceptScore W2047183713C2780306776 @default.

• next